Comparison of acute toxicity of two preparations of norcantharidin in mice
Objective ： To compare the acute toxicity of common injection and sustainedrelease preparation of norcantharidin for mice so as to identify the attenuation of the sustainedrelease preparation of norcantharidin ． Methods ： The poloxamer ４０７ was used as a sustainedrelease vehicle for topical administration of norcantharidin ，and the acute toxici ty of mice treated with common injection and sustainedrelease preparation of norcantharidin was observed ． The median lethal dose （LD５０ ） was calculated by Bliss software ． Results ： The symptoms of mice were similar between the two groups ， but the appearance of symptoms in norcantharidin／poloxamer ４０７ group was ４ hours later than that in norcantharidin group ． The LD５０ of norcantharidin administered through vein injection was １２ ．６ mg／kg ． The LD５０ of norcantharidin／poloxamer ４０７ administered through intraperitoneal injection ， intrahepatic injection and intramuscular injection were １９ ．９ ， １９ ．１ and ２０ ．９ mg／kg ， respectively ， and the LD５０ of the common preparation were １３ ．０ ， １３ ．１ and １５ ．１ mg／kg ， respectively ． Conclusion ： The norcantharidin／poloxamer ４０７ is less toxic than the equivalent dose of norcantharidin ，mainly because norcantharidin／poloxamer ４０７ may release norcantharidin sustainedly ， thus reducing norcantharidin concentration in blood ． Keywords ： sustainedrelease preparations ；poloxamer ４０７ ； acute toxicity tests Li B ， Zhu L F ， Zha ng Y N ， Gu W ． J C hin Integ r M ed ／ Zhong X i Y i J ie H e X ue B ao ，２００７ ； ５（１） ： ７４７７ ． Received Sep tembe r ５ ，２００６ ； publis hed online Januar y １５ ， ２００７ ． F ree full tex t （ PDF） is availab le at w w w ．jcimjo urnal ．com 
i ．v ：i n t rave no u s ； i ．p ： in tr a pe ri t on eal ； i ．m ： in tr a m uscu la r ； i ．h ： in t ra h epa tic 
２０ ．９ S ust ain edr elease prep a ra ti on
i ．v ：i n t rave no u s ； i ．p ： in tr a pe ri t on eal ； i ．m ： in tr a m uscu la r ； i ．h ： in t ra h epa tic ． 
